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Introduction: Risk stratification in Brugada syndrome (BS) remains
largely debated and relies to date mainly on spontaneous ECG type 1 and
symptoms. Transmural dispersion of repolarisation is a promising parameter
which has been linked to arrhythmic events in BS in a few recent works
including a limited number of patients.
Methods: ECGs from 238 BS patients were reviewed (45±12 years old,
188 males). Baseline ECG (n=126) or ECG after provocative test (n=112)
with the highest ST elevation were selected in each patient. Tpe was measured
in each 12 ECG leads. 99 patients were implanted with an ICD. 72 patients
(30%) presented an arrhythmic event defined by unexplained syncope (54 pts),
SD (8 pts) or ICD appropriated therapies (14 pts).
Results: Tpe in V1 to V4, Tpe maximum value and Tpe dispersion in pre-
cordial leads were significantly higher in symptomatic versus asymptomatic
patients (table). Tpe in peripheral leads does not add some further information.
In multivariate analysis, a Tpe>90 ms in precordial leads was an indepen-
dently related to any arrhythmic event (OR 7.29, [2.99-17.8], p<0.001), with
a sensitivity and specificity of 72% and 80% respectively.
Conclusion: Marker of transmural dispersion of repolarization such as Tpe
in precordial leads is highly related to symptoms and mortality in BS. This
simple ECG parameter could be used for further risk stratification.
Table – Tpe values according to clinical presentation
212
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Introduction: Monomorphic sustained ventricular tachycardia (MSVT) in
structural heart disease (SHD) carry poor prognosis and usually needs ICD
implantation. Whether successful RF ablation of VT in this setting could avoid
the need of ICD implantation is unknown.
Methods: 158 successive pts with SHD (133 men, age 64±10) were fol-
lowed after RF ablation of MSVT. An ICD was not implanted because of end
stage pathology (6%), advanced age (17%), well-tolerated MSVT (61%) or
preserved EF (65%). 63 pts were on amiodarone and 90 on beta-blockers.
Results: 179 procedures were performed at 7 centers. Coronary artery disease
was present in 86 pts, right ventricular dysplasia in 16 pts, dilated cardiomyopathy
in 34 pts and various SHD in the remaining. Mean EF was 48±12% (30% with
EF < 0,40). VT rate was 169±33 bpm with syncope or near-syncope in 28%. 15%
presented with electrical storm. Ablation was performed using various techniques
and end points. Complete acute success was considered achieved in 87% and
undetermined in 5 pts. Complications occurred in 17 pts (arterial dissection/occlu-
sion, tamponnade or pericardial effusion, AV block and hematomas or femoral
aneurisms). Patients were discharged on beta-blockers (99 pts) and amiodarone
(42 pts). Mean follow-up was 27±20 months. VT recurred in 16% (10±11 months)
without compromise of the vital status. Mortality rate was 17% (2 late SD)
(22±20 months). Additional RF ablations were performed again in 15 pts with
recurring VT and VT further recurred in 4 while SD occurred in 2. An ICD was
finally implanted in 7 pts. There was no difference in VT recurrence rate
according to mortality, to the cardiopathy, clinical variables, EF, VT rate and tol-
erance or to residual VT inducibility. Mortality was related to syncope, VT rate,
EF, age, residual VT inducibility, electrical storm or number of targetted VT.
Conclusions: RF ablation for VT occurring in pts with SHD without ICD
appears safe and efficient and might be now proposed as an alternative for
ICD implantation because of associated morbidity, advanced age or when VT
is well tolerated and does not occur in the context of advanced heart disease.
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Background: Despite isolated reports of Brugada pattern in inferior or lat-
eral leads, prevalence and prognostic value of ST elevation in peripheral limb
ECG leads in patients with Brugada syndrome (BS) remains poorly known.
Methods: ECGs from 238 BS patients with spontaneous or drug induced
type 1 ECG (45±12 years old, 188 males) were reviewed. Baseline ECG
(n=126) or ECG after provocative test (n=112) with the highest ST elevation
were selected in each patient. 99 patients were implanted with an ICD.
72 patients (30%) presented an arrhythmic event defined by unexplained syn-
cope (54 pts), SD (8 pts) or ICD appropriated therapies (14 pts).
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Asymptomatic 
n=166 
(70%)
Syncope 
n=54 
(23%)
SD or appropriate 
ICD therapy 
n=18 (8%)
P
Tpe V1 (ms) 62±17 75±17 88±29 <0.001
Tpe V2 (ms) 66±20 85±23 84±19 <0.001
Tpe V3 (ms) 70±18 84±25 89±20 <0.001
Tpe V4 (ms) 69±18 79±20 90±26 <0.001
Tpe V5 (ms) 68±17 72±16 72±20 0,117
Tpe V6 (ms) 66±17 71±16 72±17 0,055
Tpe max (ms) 78±15 101±19 110±24 <0,001
Tpe dispersion 
(ms)
30±11 44±20 47±26 <0,001
